List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 496 studies with search of:   "Cytarabine"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline AML and High-Risk MDS
Conditions: Acute Myeloid Leukemia;   Myelodysplastic Syndrome
Interventions: Drug: Clofarabine;   Drug: Cytarabine;   Drug: Decitabine
2 Recruiting Phase 3 Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)
Condition: Secondary Acute Myeloid Leukemia (sAML)
Interventions: Drug: Daunorubicin and Cytarabine;   Drug: Amonafide and Cytarabine
3 Recruiting Phase II Study of Idarubicin, Cytarabine, and Vorinostat in Patients With High-Risk MDS and AML
Conditions: Acute Myeloid Leukemia (AML);   Myelodysplastic Syndrome (MDS)
Interventions: Drug: Idarubicin;   Drug: Cytarabine;   Drug: Vorinostat
4 Recruiting Intrathecal DepoCyte and Lineage-Targeted Minimal Residual Disease-Oriented Therapy of Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: liposome-encapsulated cytarabine (DepoCyte);   Drug: Triple intrathecal therapy (TIT)
5 Recruiting A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I)
Condition: Acute Myelogenous Leukemia
Interventions: Drug: clofarabine (IV formulation) and cytarabine;   Drug: placebo and cytarabine
6 Recruiting Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML)
Conditions: Leukemia;   Acute Myeloid Leukemia;   AML
Interventions: Drug: Cytarabine;   Drug: Idarubicin
7 Recruiting Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias
Conditions: Richter's Transformation;   Leukemia
Interventions: Drug: Oxaliplatin;   Drug: Fludarabine;   Drug: Cytarabine;   Drug: Rituximab
8 Recruiting Study of Low-Dose Cytarabine in Combination With Arsenic Trioxide, Compared With Low-Dose Cytarabine Alone, for the Treatment of Elderly Patients With Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Interventions: Drug: Arsenic Trioxide and Low-Dose Cytarabine;   Drug: low-dose cytarabine (LDAC) plus arsenic trioxide
9 Suspended Clofarabine, Cytarabine, and Thymoglobulin for Allogeneic Transplantation
Conditions: Myelodysplastic Syndromes;   Acute Myeloid Leukemia
Interventions: Drug: Clofarabine;   Drug: Cytarabine;   Drug: Thymoglobulin;   Procedure: Stem cell infusion
10 Recruiting Rituximab-HCVAD in Patients With B-Cell Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Dexamethasone;   Drug: Methotrexate;   Drug: Cytarabine;   Drug: Prednisone
11 Recruiting Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006)
Conditions: AML;   Acute Myeloid Leukemia;   Myelodysplastic Disorders
Interventions: Drug: Idarubicin;   Drug: sorafenib;   Drug: Ara-C
12 Recruiting Safety and Tolerability Study of SNS-595 and Cytarabine Combination in Acute Myeloid Leukemia in Humans
Condition: Acute Myeloid Leukemia
Intervention: Drug: SNS-595 Injection and cytarabine
13 Recruiting Phase I/II Study of 5-Azacytidine With Ara-C in Patients With Relapsed/Refractory AML or High Risk MDS
Conditions: Acute Myelogenous Leukemia;   Myelodysplastic Syndrome;   Leukemia
Interventions: Drug: Azacitidine;   Drug: Ara-C;   Drug: Azacitidine;   Drug: Ara-C
14 Recruiting Pilot Trial of Arsenic + Cytarabine in Patients With Myelofibrosis
Condition: Myelofibrosis
Interventions: Drug: arsenic trioxide;   Drug: cytarabine
15 Recruiting Study of Clofarabine & Cytosine Arabinoside Therapy for Older Adults With Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Interventions: Drug: clofarabine;   Drug: Ara-C
16 Recruiting Study of AMG 531 to Evaluate the Safety & Efficacy in Patients With Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: AMG 531;   Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Vincristine;   Drug: Doxorubicin;   Drug: Dexamethasone;   Drug: Methotrexate;   Drug: Cytarabine;   Drug: Placebo
17 Recruiting Fludarabine, Cytarabine, G-CSF and Gemtuzumab Ozogamicin in CBF Leukemias
Condition: Acute Myelogenous Leukemia
Interventions: Drug: Fludarabine;   Drug: Cytarabine;   Drug: Filgrastim (Neupogen, G-CSF);   Drug: Gemtuzumab Ozogamicin
18 Active, not recruiting 2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES)
Condition: Leukemia
Interventions: Drug: 2-CdA;   Drug: Ara-C;   Drug: G-CSF
19 Recruiting AMD3100 Plus Mitoxantrone, Etoposide and Cytarabine in Acute Myeloid Leukemia
Condition: Leukemia, Myeloid, Acute
Interventions: Drug: AMD3100;   Drug: Mitoxantrone;   Drug: Etoposide;   Drug: Cytarabine
20 Recruiting A Study of Lintuzumab (SGN-33) in Combination With Low Dose Cytarabine in Patients 60+ Years With AML
Condition: Acute Myeloid Leukemia
Interventions: Drug: Lintuzumab (SGN-33);   Drug: Low dose cytarabine;   Drug: Placebo

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services